Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21493817 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events
Condition: Elevated High-sensitivity C-Reactive Protein (hsCRP)
Interventions: Drug: Rosuvastatin;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.